Ceres Nanosciences, Inc.

Ceres Nanosciences, Inc.

Private
Manassas, VirginiaHealthcare & Life Scienceshttps://ceresnano.com

Last Round

Grant

Sep 29, 2025

Total Funding Raised

$29.27M

Company Overview

Ceres Nanosciences, Inc. is a life sciences company that develops and commercializes products based on its proprietary Nanotrap® particle technology to improve diagnostic testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Environmental Monitoring, Advanced Materials

Business Model

B2G

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

sample preparationNanotrap technologywastewater-based epidemiologyWBEliquid biopsysample prep kitsanalyte concentrationwastewater surveillanceproteomics sample prepvirus concentrationpublic health surveillancecell-free DNAcfDNAexosome isolationresearch use only kitsRUO kitsenvironmental biosurveillancebiotech reagentshydrogel particles

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ceres Nanosciences, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ceres Nanosciences, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantSep 29, 2025
GrantAug 13, 2025
GrantDec 1, 2022
Series BSep 14, 2022
GrantApr 21, 2021
Grant
Sep 28, 2020

Key People

Founding team and executive leadership

Ross Dunlap

CEO

Executive Team

Benjamin Lepene

COO Director Or R D, Chief Technology Officer, Director Of R D

Executive Team

Ceres Nanosciences, Inc. Investors

Notable investors and investment history

InvestorRounds
Pactolus VenturesSeries A, Series A Extension
University of Virginia LVG Seed FundSeries A, Series A Extension
U.S. Department of DefenseGrant
NIH RADxGrant
Gates Family FoundationGrant
Bay Area Lyme FoundationSeries A, Series A Extension
Virginia CatalystGrant

Ceres Nanosciences, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ceres Nanosciences, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ceres Nanosciences, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersManassas, Virginia
Employee Range38
Year Founded2009
Last FundingSep 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.